2篇
您的检索式：作者名="Sandra Mazzoli"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study显示文摘 | Riccardo Bartoletti Tommaso Cai Nicola Mondaini Nicola Dinelli Novello Pinzi Carlo Pavone Paolo Gontero Andrea Gavazzi Gianluca Giubilei Domenico Prezioso Sandra Mazzoli Vieri Boddi Kurt G. Naber | 2007 | The Journal of Urology2007，，： | 1 |
| 2 | Chlamydial infections in urological disease: A challenging management显示文摘Chlamydia trachomatis(Ct) infections are the most prevalent sexually transmitted bacterial infections worldwide, causing considerable morbidity and socioeconomic problems. Moreover, Ct infections are asymptomatic in approximately 50% of infected men and 70% of infected women, with the risk for reproductive tract sequelae both in women and men. Recent studies have improved the comprehension of this infection and its natural history, also highlighting its role in decreasing male fertility. Severe complications can be avoided only by a proper early diagnosis and appropriate treatment. We reviewed the literature relating to the new findings in the treatment of Ct infection in sexually active young men. Articles from 1960-2012 were identified through a Medline search using the keywords'Chlamydia trachomatis ' combined with 'urethritis', 'epididymitis', 'prostatitis', 'treatment' or 'management'. Currently, several studies have been published about the role of new antibiotic schedules and new associated compounds in order to improve the efficacy in terms of microbiological results and patient quality of life. In particular, several studies stress the fact that Chlamydia is only metabolically active in the host cell and therefore only targeted intracellularly by antibiotics. Even although the standard therapy includes intracellularly-accumulated antibiotics such as tetracyclines or macrolides, recent evidence highlights the role of quinolones. In particular, recent studies highlight the role of prulifloxacin in the treatment of chronic prostatitis for improving the patient's quality of life and decreasing the IL-8 level. However, future studies should focus on delineating the natural history of recurrent infections, paying particular attention to treatment failures. | Tommaso Cai Paolo Verze Sandra Mazzoli Francesca Pisano Daniele Tiscione Paolo Gontero Vincenzo Mirone Riccardo Bartoletti | 2014 | World Journal of Clinical Urology2014，3，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员